| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Phreesia, Inc.'s insiders have reduced their positions by a net 536 shares worth roughly $6K. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. PHR sits in the Health Care Technology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.39M | $17.56M | - | |
| Pres | 842.5K | $10.65M | - | |
| Pres | 224.1K | $2.83M | - | |
| VP | 168.9K | $2.13M | - | |
| Other | 163.5K | $2.07M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2024 | Indig Chaim71 | Chief Executive Officer | Sell | 12,043 | $22.62 | $272,413.72 | -0.5% | -11.8% | +3.4% | |
| Apr 8, 2024 | Linetsky David71 | SVP, Life Sciences | Sell | 4,161 | $22.62 | $94,122.00 | -1.0% | -11.8% | +3.4% | |
| Apr 8, 2024 | Gunzburg Janet50 | Principal Accounting Officer | Sell | 4,526 | $23.03 | $104,218.60 | -3.7% | -11.8% | +3.4% | |
| Mar 25, 2024 | Gandhi Balaji70 | Chief Financial Officer | Sell | 3,504 | $23.21 | $81,332.04 | -3.6% | -12.0% | +22.1% | |
| Mar 21, 2024 | Roberts Evan72 | Chief Operating Officer | Sell | 25,962 | $23.52 | $610,684.38 | -1.7% | -15.1% | +16.5% | |
| Mar 20, 2024 | Linetsky David71 | SVP, Life Sciences | Sell | 30 | $23.66 | $709.79 | -0.4% | -19.5% | +14.0% | |
| Mar 20, 2024 | Gunzburg Janet50 | Principal Accounting Officer | Sell | 137 | $23.66 | $3,241.38 | -0.4% | -19.5% | +14.0% | |
| Mar 19, 2024 | Linetsky David71 | SVP, Life Sciences | Sell | 448 | $23.16 | $10,377.81 | -3.0% | -15.2% | +25.1% | |
| Feb 9, 2024 | Gunzburg Janet50 | Principal Accounting Officer | Sell | 480 | $28.00 | $13,440.00 | -1.2% | -21.3% | +3.8% | |
| Feb 2, 2024 | Gunzburg Janet50 | Principal Accounting Officer | Sell | 480 | $27.00 | $12,960.00 | -1.2% | -16.7% | +6.6% |